Evidence map›Paper›PMID 23526423›Full record

ArticleCurrent HIV/AIDS reports2013

HIV testing: current practice and future directions.

Peter Cherutich, Rebecca Bunnell, Jonathan Mermin

Abstract read
PubMed Publisher
In one paragraph

Article in Current HIV/AIDS reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. High HIV-1 RNA Among Newly Diagnosed People in Botswana.AIDS research and human retroviruses · 2018
    Article
  10. Performance evaluation of the point-of-care INSTI™ HIV-1/2 antibody test in early and established HIV infections.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2017
    Article
  11. Using a Cultural Framework to Understand Factors Influencing HIV Testing in Nigeria.International quarterly of community health education · 2016
    Article
  12. Performance evaluation of the CHEMBIO DPP® (dual path platform) HIV-1/2 assay in early and established infections.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter CherutichNational AIDS/STI Control Program, Ministry of Health, Nairobi, Kenya. pcheru@nascop.or.ke
Rebecca Bunnell
Jonathan Mermin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New approaches to expanding HIV testing and effective treatment and the wider availability of rapid testing technology have created new opportunities for achieving national and global HIV testing goals. In spite of HIV testing expansion in many settings, growing evidence of the prevention benefits of HIV testing, and the development of new, cost-effective approaches to HIV testing service provision, formidable obstacles to HIV testing expansion persist. Inequitable testing coverage exists within and across countries. While the proportion of people with HIV aware of their status is about 80% in the U.S., the majority of HIV-infected persons in Africa are unaware of their status. Testing of most-at-risk populations, couples, children, and adolescents pose still unresolved policy and programmatic challenges. Future directions for HIV testing include rapid testing technology and detection of acute HIV infection, self-testing expansion, and partner notification. Expanded routine HIV screening and widespread testing is a public health imperative to reach national and international HIV prevention and treatment goals.

Indexed as

Mass ScreeningAfricaCenters for Disease Control and Prevention, U.S.Contact TracingCost-Benefit AnalysisFemaleHIV InfectionsHumansMalePublic HealthSexual BehaviorUnited States

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.